MedTrace Logo

Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction

NCT04647435 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 396

Last updated 2025-02-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of APSCTC compared to two active drugs in acute pain relief.

Conditions

  • Postsurgical Pain
  • Third Molar Extraction

Interventions

DRUG

APSCTC

APSCTC + Toragesic® placebo + Tramal® placebo

DRUG

Toragesic®

APSCTC placebo + Toragesic® + Tramal® placebo

DRUG

Tramal®

APSCTC placebo + Toragesic® placebo + Tramal®

Sponsors & Collaborators

  • Apsen Farmaceutica S.A.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-13
Primary Completion
2024-10-04
Completion
2024-10-04

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04647435 on ClinicalTrials.gov